Developing a New Approach to Treat Multiple Sclerosis with Jesús Martin-Garcia GeNeuro

Published: Dec. 17, 2018, 8:28 p.m.

Jesús Martin-Garcia, CEO, GeNeuro discusses the need for new treatment approaches for multiple sclerosis (MS), a long lasting, often disabling disease of the central nervous system that affects 2.5 million people worldwide.  GeNeuro is developing a potential new approach for treating disease progression, the largest unmet medical need in MS, by seeking to block mechanisms suspected of driving neurodegeneration.

#MultipleSclerosis  #MS  $GNRO

GeNeuro.com